Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Katherine F Y, Chan"'
Autor:
Shawn Malone, Christopher J. D. Wallis, Richard Lee‐Ying, Naveen S. Basappa, Ilias Cagiannos, Robert J. Hamilton, Ricardo Fernandes, Cristiano Ferrario, Geoffrey T. Gotto, Scott C. Morgan, Christopher Morash, Tamim Niazi, Krista L. Noonan, Ricardo Rendon, Sebastien J. Hotte, Fred Saad, Anousheh Zardan, Brendan Osborne, Katherine F. Y. Chan, Bobby Shayegan
Publikováno v:
BJUI Compass, Vol 3, Iss 5, Pp 383-391 (2022)
Abstract Objectives To describe patterns of practice of PSA testing and imaging for Ontario men receiving continuous ADT for the treatment of non‐metastatic castration‐resistant prostate cancer (nmCRPC). Patients and Methods This was a retrospect
Externí odkaz:
https://doaj.org/article/3f6b6dfc44aa41928642415c19d064c2
Autor:
Bobby Shayegan, Christopher J. D. Wallis, Robert J. Hamilton, Scott C. Morgan, Ilinas Cagiannos, Naveen S. Basappa, Cristiano. Ferrario, Geoffrey T. Gotto, Ricardo Fernandes, Soumyajit Roy, Krista L. Noonan, Tamim Niazi, Sebastien J. Hotte, Fred Saad, Huong Hew, Laura Park-Wyllie, Katherine F. Y. Chan, Shawn Malone
Publikováno v:
Prostate Cancer and Prostatic Diseases. 26:74-79
Autor:
Bobby, Shayegan, Christopher J D, Wallis, Robert J, Hamilton, Scott C, Morgan, Ilinas, Cagiannos, Naveen S, Basappa, Cristiano, Ferrario, Geoffrey T, Gotto, Ricardo, Fernandes, Soumyajit, Roy, Krista L, Noonan, Tamim, Niazi, Sebastien J, Hotte, Fred, Saad, Huong, Hew, Laura, Park-Wyllie, Katherine F Y, Chan, Shawn, Malone
Publikováno v:
Prostate cancer and prostatic diseases.
The adoption of docetaxel for systemic treatment of metastatic prostate cancer (PCa), in both castration-sensitive (mCSPC) and castration-resistant (mCRPC) settings, is poorly understood. This study examined the real-world utilization of docetaxel in